Risk stratification after myocardial infarction;RISIKOSTRATIFIZIERUNG NACH MYOKARDINFARKT

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 23, 1996, Pages 1011-1022

  Buser, P T ^a   Osswald, St ^a   Rickenbacher, P ^a   Pfisterer, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DIURETIC AGENT;

AGE; ANGIOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HIGH RISK POPULATION; HUMAN; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CORONARY ANGIOGRAPHY; DEATH, SUDDEN, CARDIAC; FEMALE; HEART CATHETERIZATION; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 0029972923     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico: GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71.
2. The International Study Group: In-hospital mortality and clinical course of 20891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990; 336: 71-79.
3. ISIS-3 (Third International Study on Infarct Survival) Collaborative Group: ISIS-3: A randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41299 cases of suspected acute myocardial infarction. Lancet 1993; 339: 753-770.
4. The GUSTO-I Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
5. McNeer JF, Wallace AG, Wagner GS, Starmer CF, Rosati RA: The course of acute myocardial infarction: Feasibility of early discharge of the uncomplicated patient. Circulation 1975; 51: 410-413.
6. Candell-Riera J, Permanyer-Miralda G, Castell J, Ruis-Davi A, Domingo E et al.: Uncomplicated first myocardial infarction: Strategy for comprehensive prognostic studies. J Am Coll Cardiol 1991; 18: 1207-1219.
7. Shen W, Hammill S: Survivors of acute myocardial infarction: Who is at risk for sudden death? Mayo Clin Proc 1991; 66: 950-962.
8. Bodenheimer M: Risk stratification in coronary disease: A contrary viewpoint. Ann Intern Med 1992; 116: 927-936.
9. O'Rourke R: Risk stratification after myocardial infarction: Clinical overview. Circulation 1991; 84: I-177-I-181.
10. Krone R: The role of risk stratification in the early management of a myocardial infarction. Ann Intern Med 1992; 116: 223-237.
11. American College of Physicians Position Paper: Evaluation of patients after recent myocardial infarction. Ann Intern Med 1989; 110: 485-488.
12. ACC/AHA Task Force on assessment of diagnostic and therapeutic cardiovascular procedures: ACC/AHA guidelines for the early management of patients with acute myocardial infarction. Circulation 1990; 82: 664-707.
13. Crawford M: Risk stratification after myocardial infarction with exercise and doppler echocardiography. Circulation 1991; 84: I-163-I-166.
14. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A et al., for the GUSTO-I Investigators: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients. Circulation 1995; 91: 1659-1668.
15. Pfisterer M, Salamin PA, Schwendener R, Burkart F: Clinical risk assessment after first myocardial infarction - is additional noninvasive testing necessary? Chest 1992; 102: 1499-1506.
16. Rentrop KP: Restoration of antegrade flow in acute myocardial infarction: The first 15 years. J Am Coll Cardiol 1995; 25 (Suppl.): 1S-2S.
17. Holmes DR, Califf RM, Topol EJ: Lessons we have learned from the GUSTO trial. J Am Coll Cardiol 1995; 25 (Suppl.): 10S-17S.
18. Ohman EM, Califf RM, Topol EJ et al.: Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990; 82: 781-791.
19. Meijer A, Verheugt FWA, Werter CJPJ, Lie KI, van der Pol JMJ et al.: Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation 1993; 87: 1524-1530.
20. Hillis LD, Forman S, Braunwald E and the Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators: Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990; 16: 313-315.
21. Mark DB, Naylor CD, Hlatky MA, Califf RM, Topol EJ et al.: Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994; 331: 1130-1135.
22. Van de Werf F, Arnold AER for the ECSG: Effect of intravenous alteplase on infarct size, left ventricular function and survival in patients with acute myocardial infarction. Br Med J 1988; 297: 1374-1379.
23. Simoons ML, Arnold AER, Betriu A et al.: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988/I: 197-203.
24. Arnold AER, Simoons ML, Detry JMR, von Essen R, Van de Werf F et al. for the European Cooperative Study Group: Prediction of mortality following hospital discharge after thrombolysis for acute myocardial infarction: is there a need for coronary angiography? Eur Heart J 1993; 14: 306-315.
25. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E et al.: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results [see comments]. Circulation 1993; 87: 312-322.
26. Bigger JT, Fleiss JL, Kleiger R et al.: The relationship between ventricular arrhythmias, left ventricular dysfunction, and mortality in the two years after myocardial infarction. Circulation 1984; 69: 250-258.
27. Osswald S, Trouton TG, O'Nunain SS, Ruskin JN: Work up and assessment of risk for sudden death: patients with cardiac arrest and docimented ventricular fibrillation. In: Akhtar M, Myerburg RJ, Ruskin JN (Hrsg): Sudden cardiac death: prevalence, mechanisms and approaches to diagnosis. Malvern: Williams and Wilkins 1994: 465-487.
28. Myerburg RJ, Kessler KM, Bassett AL, Castellanos A: A biological approach to sudden cardiac death: structure, function and cause. Am J Cardiol 1989; 63: 1512-1516.
29. Garan H, Ruskin JN: Localized reentry. Mechanism of induced sustained ventricular tachycardia in canine model of recent myocardial infarction. J Clin Invest 1984; 74: 377-392.
30. Group MPR: Risk stratification after myocardial infarction. N Engl J Med 1983; 309: 331-336.
31. Teo KK, Yusuf S, Furberg CD: Effects of antiarrhythmic drug therapy in acute myocardial infarction. JAMA 1993; 270: 1589-1595.
32. CAST-Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412.
33. Echt DS, Liebson PR, Mitchell B, Peters RB, Obias-Manno D et al., CAST-Investistigators: Mortality and morbidity in patients receiving encainide, flecainide or placebo. N Engl J Med 1991; 324: 781-788.
34. Investigators CI: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227-233.
35. Waldo AL, Camm AJ, de Ruyter H, Friedman PL, MacNeil DJ et al., SWORD-Investigators: Preliminary mortality results from the survival without oral d-sotalol (SWORD) trial. J Am Coll Cardiol 1995; 25: 15A.
36. Yusuf S, Peto R, Lewis J, Sleight P: Betablockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985; 17: 335-371.
37. Burkart F, Pfisterer ME, Kiowski W, Follath F, Burckhardt D: Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: The Basel antiarrhythmic study of infarct survival (BASIS). J Am Coll Cardiol 1990; 16: 1711-1718.
38. Pfisterer ME, Kiowski W, Brunner H, Burckhardt D, Burkart F: Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction [see comments]. Circulation 1993; 87: 309-311.
39. Ceremuzynski L, Kleczar E, Krzeminska-Pakula M, Kuch J, Nartowicz E et al.: Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol 1992; 20: 1056-1062.
40. Singh SN, Fletcher RD, Gross Fisher S, Singh BN, Lewis HD et al.: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333: 77-82.
41. Breithardt G, Schwarzmaier M, Borggrefe M, Haerten K, Seipel L: Prognostic significance of late potentials after myocardial infarction. Eur Heart J 1983; 4: 487-495.
42. Denniss AR, Richards DA, Cody DV, Russell PA, Young T et al.: Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation 1986; 74: 731-745.
43. Kuchar DL, Thorburn CW, Samuel NL: Late potentials detected after myocardial infarction: natural history and prognostic significance. Circulation 1986; 74: 1280-1289.
44. Gomes JA, Winters SL, Martinson M, Machac J, Stewart D, Targonski A: The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol 1989; 13: 377-384.
45. Cripps TR, Camm AJ: The use of the signal-averaged electrocardiogram in predicting arrhythmic events in patients with recent myocardial infarction. Pace Pacing Clin Electrophysiol 1989; 12: 1956-1960.
46. El-Sherif N, Ursell SN, Bekheit S, Fontaine J, Turitto G et al.: Prognostic significance of the signal-averaged ECG depends on the time of recording in the postinfarction period. Am Heart J 1989; 118: 256-264.
47. Ruberman W, Weinblatt E, Goldberg JD: Ventricular premature beats and mortality after acute myocardial infarction. N Engl J Med 1977; 297: 750-757.
48. Moss AJ, Davis HT, DeCamilla J, Bayer LW: Ventricular ectopic beats and their relation to sudden and non-sudden cardiac death after myocardial infarction. Circulation 1979; 60: 998-1003.
49. Mukharji J, Rude RE, Poole WK, Gustafson N et al.: The MILLIS study group: risk factors for sudden death after acute myocardial infarction: two year follow-up. Am J Cardiol 1984; 54: 31-36.
50. Kostis JB, Byington R, Friedman LM et al.: Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol 1987; 10: 231-242.
51. Steinberg JS, Hochman JS, Morgan CD, Dorian P, Naylor CD et al.: Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation 1994; 90: 746-752.
52. Osswald S, Rickenbacher P, Buser PT, Pfisterer M: Die Abklärung von ventrikulären Rhythmusstörungen. Schweiz Rundsch Med Prax 1996; 85: 179-187.
53. Gomes JA, Winters SL, Stewart D, Horowitz S, Milner M, Barreca P: A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 1987; 10: 349-357.
54. Kornowski R, Goldbourt U, Zion M, Mandelzweig L, Kaplinsky E, Levo Y, Behar S and the SPRINT Study Group: Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. Am J Cardiol 1993; 72: 883-888.
55. Gilpin E, Ricou E, Dittrich H, Nicod P, Henning H, Ross J Jr: Factors associated with recurrent myocardial infarction within one year after acute myocardial infarction. Am Heart J 1991; 121: 457-465.
56. Morris KG, Palmeri ST, Califf RM, McKinnis RA, Higginbotham M et al.: Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. Am J Cardiol 1985; 55: 318-324.
57. Van Rugge FP, van der Wall EE, Spanjersberg SJ, de Roos A, Metheijssen NAA et al.: Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90: 127-136.